Correlation Between Ondine Biomedical and Compass Group

Can any of the company-specific risk be diversified away by investing in both Ondine Biomedical and Compass Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ondine Biomedical and Compass Group into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ondine Biomedical and Compass Group PLC, you can compare the effects of market volatilities on Ondine Biomedical and Compass Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ondine Biomedical with a short position of Compass Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ondine Biomedical and Compass Group.

Diversification Opportunities for Ondine Biomedical and Compass Group

0.66

Correlation Coefficient

Ondine Biomedical  Compass Group

Poor diversification

The 3 months correlation between Ondine and Compass is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Ondine Biomedical and Compass Group PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compass Group PLC and Ondine Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ondine Biomedical are associated (or correlated) with Compass Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compass Group PLC has no effect on the direction of Ondine Biomedical i.e., Ondine Biomedical and Compass Group go up and down completely randomly.

Pair Corralation between Ondine Biomedical and Compass Group

Assuming the 90 days trading horizon Ondine Biomedical is expected to under-perform the Compass Group. In addition to that, Ondine Biomedical is 4.93 times more volatile than Compass Group PLC. It trades about -0.01 of its total potential returns per unit of risk. Compass Group PLC is currently generating about 0.08 per unit of volatility. If you would invest  187,615  in Compass Group PLC on September 24, 2024 and sell it today you would earn a total of  77,185  from holding Compass Group PLC or generate 41.14% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Ondine Biomedical  vs.  Compass Group PLC

Ondine Biomedical

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Ondine Biomedical are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Ondine Biomedical exhibited solid returns over the last few months and may actually be approaching a breakup point.

Compass Group PLC

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Compass Group PLC are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical and fundamental indicators, Compass Group may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Ondine Biomedical and Compass Group

The main advantage of trading using opposite Ondine Biomedical and Compass Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ondine Biomedical position performs unexpectedly, Compass Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compass Group will offset losses from the drop in Compass Group's long position.

The idea behind Ondine Biomedical and Compass Group PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.